| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Allogene Therapeutics, Inc.
13G/A
Amendment 1
ALLO · 019770106
|
4.9% |
5/13/2026
Event 3/31/2026
|
|||
| David D. Chang, M.D., Ph.D. | 4.9% | ||||
| Chang 2006 Family Trust | 0.5% | ||||
| JEC 2019 Trust | 0.3% | ||||
| RTC 2019 Trust | 0.3% | ||||
|
Allogene Therapeutics, Inc.
13G
ALLO · 019770106
|
5.2% |
2/13/2026
Event 12/31/2025
|
|||
| David D. Chang, M.D., Ph.D. | 5.2% | ||||
| Chang 2006 Family Trust | 0.5% | ||||
| JEC 2019 Trust | 0.4% | ||||
| RTC 2019 Trust | 0.4% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 5
ALLO · 019770106
|
4.9% |
11/12/2025
Event 9/30/2025
|
|||
| David D. Chang, M.D., Ph.D. | 4.9% | ||||
| Chang 2006 Family Trust | 0.5% | ||||
| JEC 2019 Trust | 0.4% | ||||
| RTC 2019 Trust | 0.4% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 4
ALLO · 019770106
|
5.0% |
8/8/2025
Event 6/30/2025
|
|||
| David D. Chang, M.D., Ph.D. | 5.0% | ||||
| Chang 2006 Family Trust | 0.5% | ||||
| JEC 2019 Trust | 0.4% | ||||
| RTC 2019 Trust | 0.4% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 3
ALLO · 019770106
|
5.0% |
5/9/2025
Event 3/31/2025
|
|||
| David D. Chang, M.D., Ph.D. | 5.0% | ||||
| Chang 2006 Family Trust | 0.5% | ||||
| JEC 2019 Trust | 0.4% | ||||
| RTC 2019 Trust | 0.4% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 2
ALLO · 019770106
|
5.1% |
2/13/2025
Event 12/31/2024
|
|||
| David D. Chang, M.D., Ph.D. | 5.1% | ||||
| Chang 2006 Family Trust | 0.6% | ||||
| JEC 2019 Trust | 0.4% | ||||
| RTC 2019 Trust | 0.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.